TKL Research Agrees to Sell Clinical Trials Division

Published on: November 21, 2016

TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division to QuintilesIMS.

TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division (CTD) to QuintilesIMS. TKL Research will retain its Research Clinics Division and its CTD will become part of Novella Clinical, a subsidiary of QuintilesIMS.

Read the full release here